The global pessaries market size was valued at USD 283.46 million in 2022. It is estimated to reach USD 600.56 million by 2031, growing at a CAGR of 8.7% during the forecast period (2023–2031).
The increasing incidence of urinary incontinence, pelvic organ prolapse and the growing use of non-vascular treatment devices stimulate pessaries market growth. A prosthetic device used for structural and medicinal purposes is called a pessary. It is most frequently used to treat pelvic organ prolapse and stress urinary incontinence to keep organ placement in the pelvic area. Additionally, it can be used as a means of contraception or locally given drugs in the vagina. To prevent difficulties, people must have their pessaries fitted by medical specialists because they come in various shapes and sizes. Pessaries are most frequently used to treat pelvic organ prolapse.
A pelvic organ prolapse can happen when the tissues and muscles that normally hold the bladder, uterus, vagina, small bowel, and rectum in place fail to do so. As a result, the organs start to fall out of the body. Childbirth, generally multiple deliveries, is the most frequent cause of this prolapse. Hysterectomies, pelvic organ malignancy, long-term respiratory issues, obesity, constipation, and these conditions can also cause pelvic organ prolapses.
A frequent gynaecological disorder involving pelvic floor dysfunction in women is called Pelvic Organ Prolapse (POP). Around 30% of women between the ages of 20 and 59 have this prevalent health issue, and most women over 50 seek surgical treatment. POP surgery occurs between 1.5 and 1.8 times per 1,000 females, peaking in females between 60 and 69. POP affects over 50% of women, according to the Association for Pelvic Organ Prolapse Support.
POP surgeries are anticipated to increase demand for pessaries during the projection period. For instance, POP surgery is performed annually at a rate of roughly 300,000. Thus, rising pelvic organ prolapse rates are anticipated to support the pessary business.
Urinary incontinence and POP are treated using pessaries, a noninvasive method. Noninvasive treatment options provide several benefits, including quicker healing times, smaller or no incisions, less discomfort and scarring, improved precision, and shorter hospital stays. A secure, noninvasive approach for the treatment of POP is pessaries. To lessen the severity and frequency of prolapse symptoms and to delay or avoid the need for surgery, nonsurgical therapy is used to manage POP.
Noninvasive therapy tools like pessaries are put into the vagina to maintain the organs. They can treat stress incontinence, postpone or prevent prolapse surgery, and support pelvic floor muscle rehabilitation. The benefits of noninvasive treatment techniques are, therefore, projected to support market expansion in general.
Cost and affordability are obstacles to obtaining sufficient, cheap, nutritious food that satisfies dietary demands and food preferences for an active and nutritious life. Healthy diets can be found worldwide for between USD 3 and USD 5 per day. Healthy diet costs often exceed most countries' per capita food expenditures. Over 57% of the population in Sub–Saharan Africa and Southern Asia cannot afford these diets. Similarly, over 3 billion people worldwide do not earn sufficient income to purchase the cheapest healthy foods and dietary supplements, restricting pessaries market growth.
European countries can provide state-of-the-art medical care and cutting-edge technologies because of their robust infrastructure. The market demand in Europe, the increase in surgical treatments for POP and its long-term care with pessaries, and the expanding older population are all driven by the burden of chronic diseases. Additional market advantages include the availability of top-notch healthcare facilities and advanced diagnosis. Due to its large middle-aged population, strong government support, rising prevalence of noncommunicable diseases, notable players, and strict safety regulations, Europe is becoming important to market participants.
| Study Period | 2019-2031 | CAGR | 8.7% |
| Historical Period | 2019-2021 | Forecast Period | 2023-2031 |
| Base Year | 2022 | Base Year Market Size | USD 283.46 Million |
| Forecast Year | 2031 | Forecast Year Market Size | USD 600.56 Million |
| Largest Market | North America | Fastest Growing Market | Europe |
Based on region, the global pessaries market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the most significant pessaries market shareholder and is estimated to exhibit a CAGR of 8.9% over the forecast period. Strong medical infrastructure, a high prevalence of chronic diseases, and improvements in less invasive procedures are all variables that contribute to this. The market in North America is projected to increase due to elements like favourable insurance and medical device reimbursement regulations, a pool of big manufacturers, rising obesity rates, and a rapidly ageing population. In a poll conducted by the American Urogynecologic Society, 77% of respondents (gynaecologists) said they had first-line pessary therapy for prolapse, and 12% had prescribed pessaries to candidates who didn't meet the criteria for surgical procedures. Around 89% of gynaecologists employed a pessary to treat support abnormalities, including anterior deficiencies, posterior defects, apical defects, and full procidentia (76%). It is further mentioned that POP is still the most typical reason for physician prescriptions nationwide. These elements are anticipated to boost the pessary business in this area.
Europe is anticipated to exhibit a CAGR of 8.4% over the forecast period. After North America, Europe is a major contributor to the worldwide market for goods. European nations have a strong infrastructure that enables them to offer cutting-edge medical treatment and new technologies. The rising burden of chronic diseases drives the market demand in Europe, the rise in surgical treatments for POP and its long-term care with pessaries, and the rising elderly population. Advanced diagnosis and accessibility to top-notch healthcare facilities are further market advantages. Europe is becoming an important location for market players due to its sizable middle-aged population, strong government backing, rising prevalence of noncommunicable diseases, prominent players, and stringent safety requirements.
Asia-Pacific has emerged as one of the fastest-growing regions in the global market. The pessary market in Asia is predicted to increase profitably over the projected period due to expanding prospects, particularly in Japan, China, and India. Several reasons, including an improved regulatory framework, a rising older population, and a growth in the frequency of chronic diseases, are predicted to boost the market. In countries like India, China, and Japan, the elderly population is ageing drastically faster than ever, making them particularly susceptible to pelvic floor issues. Pessaries will become more necessary in the area. Over the projection period, growth in the prevalence of obesity and chronic respiratory disorders is anticipated throughout the growing economies of the Asia Pacific, which is predicted to be favourable for the market. A larger pool of healthcare experts, improved infrastructure, and rising POP awareness indicate the industry's predicted growth.
Latin America is one of the fastest-growing continents; Latin America offers several potentials for developing medical devices like pessaries. The epidemiological change and rising disease burden in Latin American nations are to blame for the market's good rise. Due to declining morbidity, the elderly population is also growing in Latin America. Additionally, a rise in international companies, the accessibility of surgical techniques, and clinical developments are propelling the market. Bad reimbursement policies and very shoddy healthcare infrastructure will likely constrain the market.
Middle Eastern nations with highly developed healthcare infrastructure and excellent accessibility to healthcare services include the UAE, Saudi Arabia, and Israel. These nations are popular destinations for medical tourism because they offer advanced medical systems for diagnosis and treatment. Governments have implemented several healthcare reforms and more spending to enhance citizens' healthcare. Additionally, the number of older people, the prevalence of obesity, and the incidence of chronic diseases have all increased. The elements are likely to help the local pessary market expand.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global pessaries market is bifurcated into type and end-user.
The global market is bifurcated into Gellhorn, Ring, Donut, and Others.
The ring segment dominates the global market and is projected to exhibit a CAGR of 8% over the forecast period. Clinicians prefer ring pessaries because they are simple to insert and remove. They can be used at any stage of pelvic organ prolapse (POP) and are more effective in the earliest stages of prolapse. The ring pessary resembles the diaphragm of a contraceptive in appearance. Additionally, it helps treat stress urinary incontinence and supports mild prolapse in all stages. The ease of insertion and removal by the patient or doctor is one of the benefits of the ring pessary. Thus, it is projected that the elements will grow the segment.
The global market is divided into hospitals, clinics, and ambulatory surgical centres
The hospital segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 8.2% over the forecast period. The hospital industry dominated the pharmaceutical market in 2020 and generated the largest revenue share. Most patients prefer hospitals to other locations because they are more accessible. Hospitals are also becoming increasingly popular with tourists due to their penchant for cutting-edge treatments and the rising number of patient admissions. The category is also anticipated to expand due to Medicare and Blue Cross Blue Shield's attractive reimbursement rules.
